Overview

Elliquence develops and manufactures medical devices for minimally invasive surgery, focusing on neurosurgery, endoscopic spine, orthopedic, and pain management. Its core technology is the Surgi-Max energy source that delivers 4.0 MHz radiowave energy for precise cutting, coagulation, and tissue ablation at low temperatures to minimize damage to surrounding tissue. The product lineup includes capital equipment like Surgi-Max Plus, procedure-specific systems such as Disc-FX and Trigger-Flex, and a range of endoscopes, drills, and ultrasonic bone-cutting tools, sold with disposable instruments and training services. The company differentiates itself through a heritage linked to Irving Ellman, its end-to-end offering, and its emphasis on education to promote adoption, with the goal of improving patient outcomes and expanding global use of minimally invasive spine, neurosurgical, and pain management techniques.